Published: 5/10/2022 8:46:55 AM

SyntheticMR Q1: Sales largely in-line with pre-announced figures - SEB

Q1 showed sales largely in-line with pre-announced figures from 5 April. Q1 EBIT loss (SEK -3.6m) was just in line with our estimate. With Q1 figures being in-line with previously pre-announced figures, we see limited estimate revisions post Q1. Neutral share price reaction warranted.

Link to the analysis

Read more about SyntheticMR AB